(Q73022744)
Statements
Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis (English)
E Giannini
P Borro
F Botta
B Chiarbonello
A Fasoli
F Malfatti
P Romagnoli
E Testa
D Risso
P B Lantieri
A Antonucci
M Boccato
S Milone